Heyde Pharma SRL
Heyde Pharma reported total assets of 192,810 € at the end of the 2025 financial year (annual accounts filed with the NBB on 29 Jun 2026).
The score of Heyde Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Heyde Pharma's annual accounts
| 2025 | |
|---|---|
| Net result | 122,030 € |
| Equity | 124,530 € |
| Cash | 170,385 € |
| EBITDA | 179,712 € |
| Total assets | 192,810 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Jun 2026
Heyde Pharma's financial analysis
- Solvency64.6%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Heyde Pharma
Heyde Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1011.561.035
- VAT number
- BE1011561035
- Peppol
- Registered · 0208:1011561035 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 15 Jul 2024
- Registered office
- 8490 Jabbeke
- Latest accounts
- 2025 · filed on 29 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Heyde Pharma (SRL) has been based in Jabbeke since 2024, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 122,030 € and equity of 124,530 €; its revenue is not published. Its solvency stands at 64.6%, above the median of its sector (44.2%).
Companies similar to Heyde Pharma
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie Philippe Busquin Retail sale of pharmaceutical products Morlanwelz · balance sheet 191,733 €
- Bopre Retail sale of pharmaceutical products Aalst · balance sheet 196,068 €
- Apotheek Bellens Retail sale of pharmaceutical products Lokeren · balance sheet 195,155 €
- Paracelsus Pharma Projects Retail sale of pharmaceutical products Aalter · balance sheet 197,179 €
- Panadem Retail sale of pharmaceutical products Woluwe-Saint-Pierre · balance sheet 188,078 €
- AC Bizet Retail sale of pharmaceutical products Anderlecht · balance sheet 199,908 €
- Medisame Retail sale of pharmaceutical products Stabroek · balance sheet 184,789 €
- Pharmed Retail sale of pharmaceutical products Schaerbeek · balance sheet 183,800 €
Frequently asked questions about Heyde Pharma
What is the revenue of Heyde Pharma?
Heyde Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Heyde Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE1011561035 for Heyde Pharma, if the company is VAT-registered. Its company number (CBE) is 1011.561.035.
Where is the registered office of Heyde Pharma?
According to the CBE register, the registered office of Heyde Pharma is in 8490 Jabbeke.
What is the equity of Heyde Pharma?
At the close of the 2025 financial year, the equity of Heyde Pharma amounts to 124,530 €, a solvency of 64.6% of total assets.
Who manages Heyde Pharma?
The register lists 1 active mandates at Heyde Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Heyde Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →